ANDA litigation: strategies and tactics for pharmaceutical patent litigators
- Motion for Preliminary Injunction and Temporary Restraining Order
- Subpoena for Documents
- Settlement
- Plaintiff's Interrogatories
- Appeals to the Court of Appeals for the Federal Circuit
- Scheduling Order
- Preface
- Useful Links
- Antitrust
- Plaintiff's Document Requests
- ANDA Form
- Discovery
- Pretrial Preparation
- Summary Judgment Brief on Nonobviousness
- Complaint for Declaratory Judgment
- Plaintiff's Notice of Deposition with Schedule A
- Motion for Summary Judgment and Request for Oral Argument
- Complaint
- Claim Construction
- Trial Preparation Checklist
- Plaintiff's Requests for Admissions
- Summary Judgment Brief on Noninfringement
- Expert Undertaking
- Petition to Request a Change from a Listed Drug
- Joint Pretrial Order, Consent Judgment, and Permanent Injunction as to Defendant
- Initiating Litigation
- Notice and Prefiling Considerations
- Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(1) and (6)
- Plaintiff's Claim Construction Brief
- Responding to the Complaint
- Joint Claim Construction and Prehearing Statement
- Infringement Contentions
- Covenant Not to Sue
- Inter Partes Review in ANDA Litigation
- Summary Judgment
- Pharmaceutical Regulation and Litigation in Foreign Countries
- Defendant's Requests for Admissions
- Opening Memorandum of Law in Support of Motion to Extend the Stay of FDA Approval
- Expert Report
- Unopposed Motion for Entry of Consent Judgment and Permanent Injunction as to Defendant
- Remedies
- Responsive Expert Declaration in Support of Claim Construction
- Answer, Defenses, and Counterclaims
- Hatch-Waxman Practice in the Supreme Court of the United States
- Summary Judgment Brief on Infringement
- Managing an ANDA Litigation
- Defendant's Claim Construction Brief
- Examining Subject-Matter Jurisdiction over Declaratory Judgment Claims Filed in Combination with Patent Infringement Claims under Section 271(e)(2)(A)
- The Litigation Timeline
- Summary Judgment Brief on Invalidity and Obviousness
- Paragraph IV Notice Letter
- The Drug Approval Process. An Overview
- Brief in Support of Motion in Limine?Person of Ordinary Skill in the Art
- Invalidity Contentions
- Document Authenticity Stipulation
- Brief in Opposition to Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(1) and (6)
- Protective Order
- Order Granting Motion to Extend the Stay of FDA Approval
- The Statutory and Regulatory Scheme
- Trial
- Order Granting Motion for Temporary Restraining Order and Preliminary Injunction
- Expert Declaration in Support of Claim Construction
- Posttrial
- Stipulation and Order of Infringement
- Experts
- Section vii 'Carve Out' Certification
- Defendant's Document Requests
- Defendant's Interrogatories
- Use of Reissue Proceedings in Hatch-Waxman Litigation
- Foreword
- Motion to Extend the Stay of FDA Approval
- Brief in Support of Motion in Limine?Exclude Expert Testimony
- Opening Memorandum of Law in Support of Motion for Temporary Restraining Order and Preliminary Injunction
- Defendant's Notice of Deposition with Schedule A
- Joint Pretrial Order